On the second part of the study we evaluated the effectiveness of SAA as a diagnostic biomarker of Chinese sarcoidosis compared with non-sarcoidosis groups that include healthy controls and patients with tuberculosis, interstitial lung diseases and lung cancer. This evidence concerns the gene SAA2 and tuberculosis.